Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Sartorius AG VZO

Start price
Target price
Perf. (%)
€13.00
31.05.12
€18.50
30.11.12
37.54%
30.11.12

buy
Evotec SE

Start price
Target price
Perf. (%)
€2.42
10.07.12
€3.50
31.07.12
7.67%
31.07.12

buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€51.73
14.06.12
€60.00
17.07.12
8.36%
17.07.12

buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€51.73
14.06.12
€60.00
17.07.12
8.36%
17.07.12

buy
Fresenius Medical Care AG & Co KGaA ST

Start price
Target price
Perf. (%)
€53.82
24.02.12
€60.00
25.05.12
0.09%
25.05.12

Future proof or reliable business model
Could be worthwhile Investment >10% per year
Innovative
High dividend yield expected
buy
Bayer AG

Start price
Target price
Perf. (%)
€44.32
21.11.11
€50.00
21.05.12
18.82%
21.05.12

buy
Bayer AG

Start price
Target price
Perf. (%)
€44.32
21.11.11
€50.00
21.05.12
18.82%
21.05.12

buy
Arena Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€13.18
30.01.12
€30.00
11.05.12
302.12%
11.05.12

buy
Carl Zeiss Meditec AG

Start price
Target price
Perf. (%)
€13.97
02.09.11
€17.70
14.02.12
26.78%
14.02.12

buy
Carl Zeiss Meditec AG

Start price
Target price
Perf. (%)
€13.97
02.09.11
€17.70
14.02.12
26.78%
14.02.12

buy
Merck KGaA

Start price
Target price
Perf. (%)
€32.63
10.08.11
€35.89
09.02.12
23.53%
09.02.12

buy
Merck KGaA

Start price
Target price
Perf. (%)
€37.55
29.07.11
€41.31
30.01.12
4.66%
30.01.12

buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€14.68
27.07.11
€18.00
26.01.12
25.99%
26.01.12

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€14.68
27.07.11
€18.00
26.01.12
25.99%
26.01.12

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€14.68
27.07.11
€18.00
26.01.12
25.99%
26.01.12

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
buy
Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€22.90
02.11.11
€26.67
20.01.12
8.14%
20.01.12

buy
Fresenius Medical Care AG & Co KGaA ST

Start price
Target price
Perf. (%)
€50.35
02.10.11
€53.50
28.10.11
6.26%
28.10.11

buy
Sartorius AG VZO

Start price
Target price
Perf. (%)
€6.51
18.12.10
€7.79
20.06.11
30.50%
20.06.11

buy
Sartorius AG VZO

Start price
Target price
Perf. (%)
€6.51
18.12.10
€7.79
20.06.11
30.50%
20.06.11

buy
MorphoSys AG

Start price
Target price
Perf. (%)
€21.44
01.06.11
€25.00
08.06.11
-4.64%
08.06.11

buy
MorphoSys AG

Start price
Target price
Perf. (%)
€21.44
01.06.11
€25.00
08.06.11
-4.64%
08.06.11

Gerresheimer AG

Start price
Target price
Perf. (%)
€28.42
25.11.10
€25.57
25.05.11
13.07%
25.05.11

Evotec SE

Start price
Target price
Perf. (%)
€2.78
18.05.11
€2.50
23.05.11
-6.44%
23.05.11

buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€13.88
21.11.10
€22.50
23.05.11
4.14%
23.05.11

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€13.88
21.11.10
€22.50
23.05.11
4.14%
23.05.11

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued